首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Medical Oncology

Medical Oncology杂志,由Springer US出版,于1984年创刊,Quarterly,出版语言English,ISSN:1357-0560,E-ISSN:1559-131X。

投稿咨询
Medical Oncology
Medical Oncology
Medical Oncology
SCI SCIE

杂志介绍

JCR分区
Q2
中科院分区
3区
影响因子
4.7
CiteScore
5.9
期刊收录
SCI、SCIE

Medical Oncology(中文译名:《医学肿瘤学》),ISSN:1357-0560,EISSN:1559-131X,是Springer US出版的国际性学术期刊,创刊于1984年,以Quarterly形式稳定发行,2026年总发文量约596篇。该刊采用非OA开放访问,学科归属为医学 - 肿瘤学。该刊是医学、肿瘤学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达4.7,2025年期刊CiteScore为5.9,2025年期刊自引率约4.3%,在中科院期刊分区体系中位列医学大类3区,在所属学科领域具备高学术影响力与国际认可度。Medical Oncology长期聚焦医学、肿瘤学及相关产业的技术应用前沿,平均审稿周期约1.4月,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、肿瘤学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,ItalyCHINA MAINLAND、Japan、USA、Poland、India、Brazil等为核心发文国家与地区;UNIVERSITY OF MILANIRCCS EUROPEAN INSTITUTE OF ONCOLOGY (IEO)、SAN PAOLO-POLO UNIVERSITARIA HOSPITAL、IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO、UNIVERSITY OF CALGARY、HIROSAKI UNIVERSITY、JOHNS HOPKINS UNIVERSITY等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
ONCOLOGY 肿瘤学
3区
否 否

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
ONCOLOGY 肿瘤学
4区
否 否

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
ONCOLOGY 肿瘤学
4区
否 否

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q2 97 / 333

71

学科:ONCOLOGY SCIE Q2 144 / 333

56.91

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q2 106 / 328

67.8

学科:ONCOLOGY SCIE Q2 146 / 328

55.64


中国学者近期发文

1
Exploration of the mechanism by which Ubiquitin-like protein UBD promotes malignant progression of breast cance

Author:Ma, Lei; Xie, Bei; Zhang, Rongzhi; Deng, Haohua; Tang, Baoyuan; Zhu, Jinmei; Zhang, Ziqing; Ma, Xingyuan; Wang, Shuaiyang; Li, Linjing

Journal: MEDICAL ONCOLOGY. 2026; Vol. 43, Issue 6, pp. -. DOI: 10.1007/s12032-025-03168-4

2
Diosmetin overcomes resistance to cisplatin in ovarian cancer by suppressing the MAPK signaling pathwa

Author:Nie, Juan; Jiang, Hequn; Zhou, Runyu; Gong, Ruichen; Xu, Wenli; Zhang, Ping; Lu, Ling; Lyu, Lin

Journal: MEDICAL ONCOLOGY. 2026; Vol. 43, Issue 5, pp. -. DOI: 10.1007/s12032-026-03293-8

3
RETRACTION: The c-Myc-LDHA axis positively regulates aerobic glycolysis and promotes tumor progression in pancreatic cance

Author:He, Tian-Lin; Zhang, Yi-Jie; Jiang, Hui; Li, Xiao-hui; Zhu, Hai; Zheng, Kai-Lian

Journal: MEDICAL ONCOLOGY. 2026; Vol. 43, Issue 5, pp. -. DOI: 10.1007/s12032-026-03296-5

4
A novel matrine derivative exerts antitumor effects against hepatocellular carcinoma by inducing oxidative stress and DNA damag

Author:Hu, Zhouxing; Wang, Xingdong; Xu, Tingguo; Ou, Anqi; Song, Yuanbo; Wang, Lisheng

Journal: MEDICAL ONCOLOGY. 2026; Vol. 43, Issue 4, pp. -. DOI: 10.1007/s12032-026-03243-4

5
Research progress and clinical translation challenges in the use of oncolytic bacteria for cancer therap

Author:Lu, Min; Sun, Zhimin; Qian, Yimin; Guo, Jingxu; Liang, Yaping; Han, Kexin; Yan, Weiyuan; Gao, Yaxin; Wang, Kou; Jiang, Minjie; Liu, Yueling; Yang, Bin; Wang, Yan; Tang, Naping

Journal: MEDICAL ONCOLOGY. 2026; Vol. 43, Issue 4, pp. -. DOI: 10.1007/s12032-026-03269-8

6
Dysregulated immune microenvironment in metastatic colorectal cance

Author:An, Shuaixing; Yu, Zhaojin; Li, Jianping; Wei, Minjie

Journal: MEDICAL ONCOLOGY. 2026; Vol. 43, Issue 4, pp. -. DOI: 10.1007/s12032-025-03112-6

7
Elbasvir triggers ferroptosis in esophageal squamous cell carcinoma through NCOA4-mediated ferritinophag

Author:Tang, Maoju; Gong, Feng; Yang, Miyuan; He, Shuang; Cheng, Jiao; Yang, Zhiheng; Xu, Lei; Ma, Qiang; Guo, Xiaolan; Zhong, Xiaowu

Journal: MEDICAL ONCOLOGY. 2026; Vol. 43, Issue 3, pp. -. DOI: 10.1007/s12032-026-03249-y

8
Engineered mesenchymal stem cells expressing CXCR4 and LIGHT enhance Anti-Tumor activity in a subcutaneous gastric cancer xenograft mode

Author:Anayyat, Umer; Ye, Jianbin; Wu, Xumin; Liu, Zhiyu; Liao, Cui; Wang, Xiaomei; Liu, Muyun

Journal: MEDICAL ONCOLOGY. 2026; Vol. 43, Issue 3, pp. -. DOI: 10.1007/s12032-026-03271-0

9
A trifluoromethyl quinoline derivative targets SGK1 and modulates the PI3K/AKT pathway to inhibit prostate cancer progressio

Author:Yang, Xianhui; Wang, Rui; Xu, Guangcan; Yang, Ziqi; Yao, Xingsheng; Liu, Guangyang; Yu, Jia; Xu, Bixue; Luo, Heng; Cao, Ying

Journal: MEDICAL ONCOLOGY. 2026; Vol. 43, Issue 3, pp. -. DOI: 10.1007/s12032-026-03256-z

10
Structural and functional insights into CD3 bispecific antibodies targeting DLL3 in cancer immunotherap

Author:Chen, Shanshan; Zhang, Guangshun; He, Xiangyi; Li, Yuze; Li, Dong

Journal: MEDICAL ONCOLOGY. 2026; Vol. 43, Issue 3, pp. -. DOI: 10.1007/s12032-025-03232-z


在线咨询

Medical Oncology

国际简称:MED ONCOL参考译名:医学肿瘤学

年发文量:596 CiteScore:5.9 是否预警:否 Gold OA文章占比:14.25% 研究类文章占比:52.68%

杂志社联系方式:HUMANA PRESS INC, 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, USA, NJ, 07512

Medical Oncology